Smoldering Multiple Myeloma – to treat or not to treat?
februari 7, 2024Smoldering multiple myeloma (SMM) is an intermediate condition that lies between Monoclonal gammopathy of undetermined significance (MGUS) and active multiple…MGRS- Monoclonal Gammopathy of Renal Significance
oktober 26, 2023Monoclonal gammopathy of renal significance (MGRS) is a hemato-nephrological term referring to a heterogeneous group of kidney disorders characterized by…Extramedullar disease in Multiple Myeloma
juli 7, 2023Experts call for a better understanding of how myeloma cells grow and thrive and the biology of extramedullary tumors in…Recent findings in MGUS
april 15, 2023Professor Kristinsson will bring us up to date on recent understandings of the MGUS condition, what symptoms we as health…Mental health during and after cancer treatment
december 14, 2022In this episode we discuss the severe impact a physical illness can have on mental health.MRD as primary endpoint
november 29, 2021With help from Professor Ola Landgren, we will look into the crystal ball and discover what the future may hold…Minimal Residual Disease (MRD) – Cost vs Benefit
oktober 28, 2021Detection of Minimal Residual Disease (MRD) is becoming more important in different fields of hematology including Multiple Myeloma. Over the…
